Displaying 13 - 24 of 32

Display:

12 24 48

Metabolism, Alcohol & Toxicity

6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View

Metabolism, Alcohol & Toxicity

6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View

Metabolism, Alcohol & Toxicity

6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View

Metabolism, Alcohol & Toxicity

6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View

Metabolism, Alcohol & Toxicity

6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View

Cirrhosis & Complications

5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View

Cirrhosis & Complications

5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View

Cirrhosis & Complications

5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View

Cirrhosis & Complications

5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View

Cirrhosis & Complications

5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View

Cirrhosis & Complications

4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View

Cirrhosis & Complications

4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View

Displaying 13 - 24 of 32

Display:

12 24 48